Breaking News on Supplements, Health & Nutrition - Europe US edition | APAC edition

Read more breaking news



One-third of Chinese infant formula production permits not renewed: SFDA

By Mark Astley+


One-third of Chinese infant formula production permits not renewed

Production permits held by more than one third of China's infant formula manufacturers have not been renewed, following a six-month campaign to boost the standard of domestically-made products.

In a statement issued late last week, the China Food and Drug Administration (SFDA) said that just 82 of the 133 infant formula manufacturers that applied have been granted permits. 

The remaining 51 manufacturers "failed or applied to postpone the investigation and some of them withdrew from the industry," reported China Central Television (CCTV). 

These firms will be forced to cease production this month, it added.

In line with new Chinese government regulations designed to "further strengthen the quality and safety" of infant formula products made in the country, the SFDA developed "a series of measures." 

The revised regulation, Infant Formula Milk Powder Production License Examination Rules (2013 edition), was issued in December 2013. It increased requirements in areas including the purchase of raw materials, product inspection, product traceability, and product safety control.

The 82 companies handed renewed permits spent nearly 2.5bn yuan (US$400m, €295m) to ensure their lines met these new requirement, CCTV also reported.

Alongside its assault on domestic infant formula manufacturers, China has also clamped down on the influx of foreign infant formula firms in an effort to help domestic manufacturers reclaims a larger share of the market.

In line with the State General Administration of the People’s Republic of China for Quality Supervision and Inspection and Quarantine (AQSIQ)-issued Decree 145, foreign authorities are now required to provide the Certification and Accreditation Administration of China (CNCA) with a list of approved dairy manufacturers. 

In late April 2014, just days before the new Chinese rules came into force, scores of New Zealand infant formula manufacturers and brand owners were warned that their products could be temporarily denied entry into China.

Related products

Live Supplier Webinars

Polyphenols tipped to become the way to innovate in Sports Nutrition
Alpha & Omega in Sports Nutrition – Using Omega 3’s and A-GPC to improve performance and recovery.
KD Pharma
Orally bioavailable standardized botanical derivatives in sport nutrition: special focus on recovery in post-intense physical activities
Collagen in motion: move freely and keep your injuries in check
Leading manufacturer of gelatine and collagen peptides
Life’s too short for slow proteins. Whey proteins hydrolysates: Fast delivery for enhanced performance
Arla Foods Ingredients
What it Takes to Compete and Win in Today’s Sports Nutrition Market
Sports Nutrition Snapshot: Key regional drivers and delivery format innovations
William Reed Business Media
Gutsy performance: How can microbiome modulation help athletes and weekend warriors
William Reed Business Media
Pushing the boundaries: Where’s the line between ‘cutting edge nutrition’ and doping
William Reed Business Media

On demand Supplier Webinars

High-amylose maize starch may reduce the risk of type 2 diabetes: what does this qualified health claim mean?
Balancing Innovation and Risk in Sports Nutrition Ingredients
Explaining bio-hacking: is there a marketing opportunity for food companies?
William Reed Business Media
Personalized Nutrition – how an industry can take part in shaping the future of Nutrition
BASF Nutrition & Health
Find out Nutritional and ingredient lifecycle solutions and strategies!
Is the time rIpe for I-nutrition?
William Reed Business Media
The Advantage of Outsourcing Fermentation-based Manufacturing Processes
Evonik Health Care
All supplier webinars